Thomas Graham, Alan, Irving KahnsKahn Brothers Group Portfolio Activity & Recent Trades (Sep 30, 2025)


As of Sep 30, 2025, the Kahn Brothers Group portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Nov 12, 2025. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.


During Q3 2025, the filing reported:



These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

DateSymbolTypeChange Qty
Q3 2025
32112J106
First National Bank Alaska
Sell
-1,300
Q3 2025
717046106
Peyto Exploration
Sell
-450
Q3 2025
722524105
Pine Cliff Energy
Sell
-10,000
Q3 2025
89156V106
Tourmaline Oil
Sell
-3,550
Q3 2025
896CNT011
Trinity Place
Sell - Position Exit
-166,999
Q3 2025
AIG
American International Group, I
Sell - Position Exit
-2,349
Q3 2025
AR
Antero Resources Corporation
Sell
-7,064
Q3 2025
AXP
American Express Company
Buy - Position Entry
+1,150
Q3 2025
BAC
Bank of America Corporation
Sell
-761
Q3 2025
BAYRY
Bayer A.G.
Buy
+58,350
Q3 2025
BMY
Bristol-Myers Squibb Company
Sell
-278,349
Q3 2025
BN
Brookfield Corporation
Buy - Position Entry
+3,380
Q3 2025
BP
BP p.l.c.
Sell
-43,765
Q3 2025
C
Citigroup, Inc.
Sell
-10,028
Q3 2025
CVX
Chevron Corporation
Sell
-50
Q3 2025
DIS
Walt Disney Company (The)
Buy
+2,074
Q3 2025
G0585R106
Assured Guaranty
Sell
-41,396
Q3 2025
GNE
Genie Energy Ltd.
Sell
-7,127
Q3 2025
GOOG
Alphabet Inc.
Buy
+63,631
Q3 2025
GSK
GSK plc
Sell
-399,035
Q3 2025
HLN
Haleon plc
Sell
-50,410
Q3 2025
IDT
IDT Corporation
Sell
-4,207
Q3 2025
JPM
JP Morgan Chase & Co.
Sell
-107
Q3 2025
MBI
MBIA Inc.
Buy - Position Entry
+1,029,794
Q3 2025
MRK
Merck & Company, Inc.
Sell
-56,715
Q3 2025
NVDA
NVIDIA Corporation
Buy - Position Entry
+1,740
Q3 2025
NVS
Novartis AG
Sell
-4,145
Q3 2025
NYCB
NY Community Bancorp
Sell
-24,413
Q3 2025
OGN
Organon & Co.
Buy
+126,695
Q3 2025
PFE
Pfizer, Inc.
Sell
-23,845